|
PSRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.993600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.617800E-02 |
| Normal-vs-Stage2 |
9.401800E-02 |
| Normal-vs-Stage3 |
1.587430E-01 |
| Normal-vs-Stage4 |
6.950800E-01 |
| Stage1-vs-Stage2 |
9.135400E-01 |
| Stage1-vs-Stage3 |
2.788800E-01 |
| Stage1-vs-Stage4 |
1.333190E-01 |
| Stage2-vs-Stage3 |
4.700800E-01 |
| Stage2-vs-Stage4 |
2.504000E-01 |
| Stage3-vs-Stage4 |
4.723600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.830000E-02 |
| Normal-vs-AfricanAmerican |
5.895400E-01 |
| Normal-vs-Asian |
2.524000E-01 |
| Caucasian-vs-AfricanAmerican |
1.049020E-01 |
| Caucasian-vs-Asian |
6.682800E-01 |
| AfricanAmerican-vs-Asian |
1.862570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.627900E-02 |
| Normal-vs-Female |
7.286400E-02 |
| Male-vs-Female |
8.891000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.631710E-02 |
| Normal-vs-Age(41-60Yrs) |
9.354500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.155800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.837600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.059400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.792190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.499600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.692000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.897200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.194800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.705000E-01 |
| Classical-VS-Follicular |
5.237600E-01 |
| Classical-VS-Other |
5.316800E-01 |
| Classical-VS-Normal |
5.356500E-02 |
| Tall-VS-Follicular |
9.786400E-01 |
| Tall-VS-Other |
7.545000E-01 |
| Tall-VS-Normal |
2.664000E-01 |
| Follicular-VS-Other |
6.845800E-01 |
| Follicular-VS-Normal |
2.025000E-01 |
| Other-VS-Normal |
8.675000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.811380E-01 |
| Normal-vs-N1 |
3.104700E-03 |
| N0-vs-N1 |
3.866000E-02 |
|
|
